EPI-003 clinical trials
EPI-003 is named as an intervention in 2 current clinical trials in our China and Australia registers. None are recruiting at the moment. The most common phase is Phase 1. The lead sponsor is Epigenic Therapeutics, Inc. The most-studied condition is Chronic Hepatitis B.
Patient leaflets for EPI-003
The package leaflet is the official guide for patients that comes with every medicine. These links go to the regulators that publish it.
- UKUnited Kingdom: Search MHRA ProductsPatient information leaflets and SmPCs for UK-licensed products.
- USUnited States: Search DailyMedFDA-approved labels, including patient and medication guides.
Leaflets differ between brands and countries; always read the one that comes with your own medicine. This is regulatory information, not medical advice.
Trials by status
Trials by phase
Clinical trials of EPI-003
2 trials| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
Study of EPI-003 in Select Nucleos(t)Ide Analogue-Treated, Chronic Hepatitis B Patients
NCT06661148 · Chronic Hepatitis B, HBV (Hepatitis B Virus)
|
Phase 1 | Not yet open | Epigenic Therapeutics, Inc | China, Australia |
|
An Exploratory Clinical Study Evaluating EPI-003 Injection for the Treatment of Chronic Hepatitis B
NCT06745973 · ClinicalTrials.gov ↗ · Chronic Hepatitis B
|
Early Phase 1 | Not yet open | Epigenic Therapeutics, Inc | China |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
Conditions studied with EPI-003
2 conditionsSponsors
lead sponsor per trial| Lead sponsor | Trials |
|---|---|
| Epigenic Therapeutics, Inc | 2 |
By country register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in China | 2 | 0 |
| Clinical trials in Australia | 1 | 0 |
A trial with sites in more than one country appears in each of those registers.
Related compounds
Questions about EPI-003 trials
How many clinical trials are testing EPI-003?
2 current trials in our China and Australia registers name EPI-003 as a drug or biological intervention, as of the registry sync on 17 November 2026. Completed and withdrawn studies are not counted.
Are EPI-003 trials recruiting patients?
Not at the moment. None of the 2 trials in our registers is recruiting; they are active but closed to enrolment, not yet open, or enrolling by invitation. Only the study team can confirm whether a patient is eligible.
Who sponsors EPI-003 clinical trials?
The lead sponsor is Epigenic Therapeutics, Inc. The number in brackets is how many trials each organisation leads.
Where does this information come from?
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how EPI-003 works or whether it is effective, and it is not medical advice.
How this page is built
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how EPI-003 works or whether it is effective. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, intervention names and synonyms, phase, overall status, lead sponsor and conditions for every trial on this page
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists EPI-003 (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 17 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.